참고문헌
- Agnoli C, F Berrino, CA Abagnato, et al (2009). Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis, 20, 41-8.
- Balkwill F, KA Charles, A Mantovani, et al (2005). Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell, 7, 211-7. https://doi.org/10.1016/j.ccr.2005.02.013
- Balleyguier C, S Ayadi, K Van Nguyen, et al (2007). BIRADS classification in mammography. Eur J Radiol, 61, 192-4. https://doi.org/10.1016/j.ejrad.2006.08.033
- Bjorge T, A Lukanova, H Jonsson, et al (2010). Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev, 19, 1737-45. https://doi.org/10.1158/1055-9965.EPI-10-0230
- Craig CL, AL Marshall, M Sjostrom, et al (2003). International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc, 35, 1381-95. https://doi.org/10.1249/01.MSS.0000078924.61453.FB
- Chilean Ministry of Health, SD (2008). Estadisticas Vitales. Retrieved 06/06, 2011, from http://deis.minsal.cl/deis/vitales/vita.asp.
- Chobanian AV, GL Bakris, HR Black, et al (2003). Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 42, 1206-52. https://doi.org/10.1161/01.HYP.0000107251.49515.c2
- Dubey RK, S Oparil, B Imthurn, et al (2002). Sex hormones and hypertension. Cardiovasc Res, 53, 688-708. https://doi.org/10.1016/S0008-6363(01)00527-2
- Ferlay J, Shin HR, F Bray, et al (2010). Available from: http://globocan.iarc.fr ). GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer.
- Franceschi S, C la Vecchia, E Negri, et al (1990). Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer, 26, 781-5. https://doi.org/10.1016/0277-5379(90)90151-I
- Garmendia ML, A Pereira, ME Alvarado, et al (2007). Relation between insulin resistance and breast cancer among Chilean women. Ann Epidemiol, 17, 403-9. https://doi.org/10.1016/j.annepidem.2007.01.037
- Giovannucci E (1995). Insulin and colon cancer. Cancer Causes Control, 6, 164-79. https://doi.org/10.1007/BF00052777
- Greene FL, CC Compton, AG Fritz, et al (2006). AJCC Cancer Staging Atlas. New York, NY, Springer Science+Business Media, Inc.
- Greenland S, J Pearl, JM Robins, et al (1999). Causal diagrams for epidemiologic research. Epidemiology, 10, 37-48. https://doi.org/10.1097/00001648-199901000-00008
- Grossman E, FH Messerli, V Boyko, et al (2002). Is there an association between hypertension and cancer mortality? Am J Med, 112, 479-86. https://doi.org/10.1016/S0002-9343(02)01049-5
- Hamet P (1997). Cancer and hypertension: a potential for crosstalk? J Hypertens, 15, 1573-7. https://doi.org/10.1097/00004872-199715120-00058
- Hernan MA, S Hernandez-Diaz, MM Werler, et al (2002). Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol, 155, 176-84. https://doi.org/10.1093/aje/155.2.176
- Hunter DJ, WC Willett (1993). Diet, body size, and breast cancer. Epidemiol Rev, 15, 110-32. https://doi.org/10.1093/oxfordjournals.epirev.a036096
- Kabat GC, M Kim, RT Chlebowski, et al (2009). A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev, 18, 2046-53. https://doi.org/10.1158/1055-9965.EPI-09-0235
- Key TJ, PK Verkasalo, E Banks, et al (2001). Epidemiology of breast cancer. Lancet Oncol, 2, 133-40. https://doi.org/10.1016/S1470-2045(00)00254-0
- La Vecchia C, E Negri, S Franceschi, et al (1997). Body mass index and post-menopausal breast cancer: an age-specific analysis. Br J Cancer, 75, 441-4. https://doi.org/10.1038/bjc.1997.73
- Largent JA, L Bernstein, PL Horn-Ross, et al (2010). Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes Control, 21, 1615-24. https://doi.org/10.1007/s10552-010-9590-x
- Largent JA, AJ McEligot, A Ziogas, et al (2006). Hypertension, diuretics and breast cancer risk. J Hum Hypertens, 20, 727-32. https://doi.org/10.1038/sj.jhh.1002075
- Li CI, KE Malone, NS Weiss, et al (2003). Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer, 98, 1504-13. https://doi.org/10.1002/cncr.11663
- Li JJ, CH Fang, RT Hui, et al (2005). Is hypertension an inflammatory disease? Med Hypotheses, 64, 236-40. https://doi.org/10.1016/j.mehy.2004.06.017
- Lindgren A, E Pukkala, J Tuomilehto, et al (2007). Incidence of breast cancer among postmenopausal, hypertensive women. Int J Cancer, 121, 641-4. https://doi.org/10.1002/ijc.22689
- Mackenzie IS, TM Macdonald, A Thompson, et al (2012). Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study. BMJ, 345, 4447. https://doi.org/10.1136/bmj.e4447
- Madigan MP, RG Ziegler, J Benichou, et al (1995). Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst, 87, 1681-5. https://doi.org/10.1093/jnci/87.22.1681
- Matthews DR, JP Hosker, AS Rudenski, et al (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-9. https://doi.org/10.1007/BF00280883
- Ministerio de Salud (2010). Encuesta Nacional de Salud (ENS) Chile 2009-2010,. Santiago, Chile.
- Muti P, T Quattrin, BJ Grant, et al (2002). Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev, 11, 1361-8.
- National Cholesterol Education Program (NCEP) (2002). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation, 106, 3143-421.
- Peeters PH, PA van Noord, AW Hoes, et al (2000). Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer. J Hypertens, 18, 249-54. https://doi.org/10.1097/00004872-200018030-00002
- Porter PL (2009). Global trends in breast cancer incidence and mortality. Salud Publica Mex, 51, 141-6. https://doi.org/10.1590/S0036-36342009000800003
- Reeves KW, V McLaughlin, L Fredman, et al (2012). Components of metabolic syndrome and risk of breast cancer by prognostic features in the study of osteoporotic fractures cohort. Cancer Causes Control, 23, 1241-51. https://doi.org/10.1007/s10552-012-0002-2
- Robins JM (2001). Data, design, and background knowledge in etiologic inference. Epidemiology, 12, 313-20. https://doi.org/10.1097/00001648-200105000-00011
- Ronco AL, E De Stefani, H Deneo-Pellegrini, et al (2012). Risk factors for premenopausal breast cancer: a case-control study in Uruguay. Asian Pac J Cancer Prev, 13, 2879-86. https://doi.org/10.7314/APJCP.2012.13.6.2879
- Ronco AL, E De Stefani, H Deneo-Pellegrini, et al (2012). Diabetes, overweight and risk of postmenopausal breast cancer: a case-control study in Uruguay. Asian Pac J Cancer Prev, 13, 139-46. https://doi.org/10.7314/APJCP.2012.13.1.139
- Rosato V, C Bosetti, R Talamini, et al (2011). Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol, 22, 2687-92. https://doi.org/10.1093/annonc/mdr025
- Soler M, L Chatenoud, E Negri, et al (1999). Hypertension and hormone-related neoplasms in women. Hypertension, 34, 320-5. https://doi.org/10.1161/01.HYP.34.2.320
- Toniolo P, PF Bruning, A Akhmedkhanov, et al (2000). Serum insulin-like growth factor-I and breast cancer. Int J Cancer, 88, 828-32. https://doi.org/10.1002/1097-0215(20001201)88:5<828::AID-IJC22>3.0.CO;2-8
- World Health Organization (1995). Physical status: The use and interpretation of anthropometry. WHO Technical Report Series. Geneva, WHO.
- Xue F, KB Michels (2007). Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr, 86, 823-35. https://doi.org/10.1093/ajcn/86.3.823S
피인용 문헌
- Metabolic dysregulation and cancer mortality in a national cohort of blacks and whites vol.17, pp.1, 2017, https://doi.org/10.1186/s12885-017-3807-2
- Risk factors of breast cancer and knowledge about the disease: an integrative revision of Latin American studies vol.22, pp.1, 2017, https://doi.org/10.1590/1413-81232017221.09272015
- Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies vol.40, pp.1, 2018, https://doi.org/10.1080/10641963.2017.1288736
- Hypertension and Subsequent Genitourinary and Gynecologic Cancers Risk vol.94, pp.16, 2015, https://doi.org/10.1097/MD.0000000000000753
- Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype pp.1573-7217, 2018, https://doi.org/10.1007/s10549-018-5056-8
- Cancer and comorbidity: The role of leptin in breast cancer and associated pathologies vol.6, pp.12, 2018, https://doi.org/10.12998/wjcc.v6.i12.483
- Metabolic Syndrome and the Risk of Breast Cancer and Subtypes by Race, Menopause and BMI vol.10, pp.9, 2018, https://doi.org/10.3390/cancers10090299